Spatially encoded biological assays

Patent metadata

Field	Value
Publication number	US-12297488-B2
Application number	US-202418972148-A
Country	US
Kind code	B2
Filing date	Dec 6, 2024
Priority date	Apr 5, 2010
Publication date	May 13, 2025
Grant date	May 13, 2025

Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

First claim

The invention claimed is:

1. A method for determining a presence of a nucleic acid at a location in a tissue section comprising:
(a) contacting the tissue section with a substrate comprising a plurality of features, wherein a feature of the plurality of features comprises a capture agent, wherein the capture agent comprises:
(i) a first sequence that binds the nucleic acid, and
(ii) a second sequence comprising a coding tag, wherein a sequence of the coding tag corresponds to a location of the capture agent on the substrate;

(b) determining the sequence of the coding tag, or a complement thereof, and all or a portion of the sequence of the nucleic acid bound to the capture agent, or a complement thereof; and
(c) visualizing a spatial location of the nucleic acid in the tissue section corresponding to the determined sequence.

2. The method of claim 1 , wherein the capture agent is directly immobilized on the substrate.

3. The method of claim 1 , wherein the capture agent is indirectly immobilized on the substrate.

4. The method of claim 1 , wherein the capture agent is immobilized in a well on the substrate.

5. The method of claim 1 , wherein the substrate is incorporated into a flow cell.

6. The method of claim 1 , wherein the substrate is incorporated onto a slide.

7. The method of claim 1 , wherein the determining comprises sequencing.

8. The method of claim 1 , wherein the nucleic acid is DNA.

9. The method of claim 1 , wherein the nucleic acid is RNA.

10. The method of claim 1 , wherein the plurality of features comprises wells.

11. The method of claim 1 , wherein the tissue section is a fresh frozen tissue section.

12. The method of claim 1 , wherein the tissue section is a formalin fixed paraffin embedded tissue section.

13. The method of claim 1 , wherein the method further comprises staining the tissue section.

14. The method of claim 1 , wherein the method further comprises imaging the tissue section.

15. The method of claim 1 , wherein the substrate comprises greater than 10,000 features.

16. The method of claim 1 , wherein the capture agent further comprises a primer binding site.

17. The method of claim 1 , wherein multiple tissue sections are contacted with the substrate.

18. The method of claim 1 , wherein the method further comprises determining the abundance of the nucleic acid in the tissue section.

19. The method of claim 1 , wherein the tissue section is permeabilized prior to step (b).

20. A method for spatial analysis comprising:
(a) contacting a tissue section with a substrate of a flow cell, wherein the substrate comprises a plurality of wells, wherein a well of the plurality of wells comprises a capture agent immobilized therein, and wherein the capture agent comprises:
(i) a first sequence that binds a nucleic acid of the tissue section, and
(ii) a second sequence comprising a coding tag, wherein a sequence of the coding tag corresponds to a location of the capture agent on the substrate;
wherein nucleic acids of the tissue section are bound to capture agents at locations of the substrate that correspond to locations of the nucleic acids in the tissue section;

(b) determining the sequence of the coding tag, or a complement thereof, and all or a portion of the sequence of the nucleic acid bound to the capture agent, or a complement thereof; and
(c) visualizing a spatial location of the nucleic acids in the tissue section corresponding to the determined sequences.

21. The method of claim 20 , wherein the capture agent is directly immobilized in the well of the substrate.

22. The method of claim 20 , wherein the capture agent is indirectly immobilized in the well of the substrate.

23. The method of claim 20 , wherein the determining comprises sequencing.

24. The method of claim 20 , wherein the nucleic acid is RNA.

25. The method of claim 20 , wherein the tissue section is a fresh frozen tissue section.

26. The method of claim 20 , wherein the method further comprises staining the tissue section.

27. The method of claim 20 , wherein the method further comprises imaging the tissue section.

28. The method of claim 20 , wherein the capture agent further comprises a primer binding site.

29. The method of claim 20 , wherein multiple tissue sections are contacted with the substrate.

30. The method of claim 20 , wherein the method further comprises determining the abundance of the nucleic acids in the tissue section.

Assignees

• Prognosys Biosciences Inc

Inventors

• Chee Mark S

Classifications

• G01N2458/40

  Rare earth chelates · CPC title

• G01N33/6848

  Methods of protein analysis involving mass spectrometry · CPC title

• C12Q2600/158

  Expression markers · CPC title

• C12Q2600/156

  Polymorphic or mutational markers · CPC title

• C12Q1/6858

  Allele-specific amplification · CPC title